EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials

Mika Ukkonen iD, Antti Kivivuori, Peter Starckjohann, Pekka Lammi, Anna Junttila, Valtteri Panula

Diabetes, Obesity and Metabolism · 2026-10 · 28 (10) · 9701-9703

DOI: 10.1111/dom.71087 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 06.07.2026. Verfasst von Mika Ukkonen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Wellbeing Services of County of Central Finland, Jyväskylä, Finland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1meta‐analysissemaglutideweight management

Autor:innen und Institutionen

  • Department of Surgery, Wellbeing Services of County of Central Finland, Jyväskylä, Finland.
  • School of Medicine, University of Eastern Finland, Kuopio, Finland.
  • Department of Surgery, Kuopio University Hospital, Kuopio, Finland.

ORCID-Profile: Mika Ukkonen

Zitieren

APA

Ukkonen, M., Kivivuori, A., Starckjohann, P., Lammi, P., Junttila, A., & Panula, V. (2026). Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials. Diabetes, Obesity and Metabolism, 28(10), 9701-9703. https://doi.org/10.1111/dom.71087

Vancouver

Ukkonen M, Kivivuori A, Starckjohann P, Lammi P, Junttila A, Panula V. Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials. Diabetes, Obesity and Metabolism. 2026;28(10):9701-9703. doi:10.1111/dom.71087

BibTeX
@article{Ukkonen2026,
  author = {Ukkonen, Mika and Kivivuori, Antti and Starckjohann, Peter and Lammi, Pekka and Junttila, Anna and Panula, Valtteri},
  title = {Gallbladder‐Related Adverse Events With Semaglutide 2.4 mg: Pooled Analysis of Placebo‐Controlled STEP Trials},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {10},
  pages = {9701--9703},
  doi = {10.1111/dom.71087}
}
Kostenlos starten →